Back to search

Article

Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex Binding

2022-06-01

Abstract excerpt

The COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) are nucleic acid secondary structures known to affect many cellular processes including viral replication and transcription. We identified heretofore not reported G4s w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3294415-5f80-5abd-954a-091a0a138ec4
DOI
10.1101/2022.05.31.493843
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex BindingDOI 10.1101/2022.05.31.493843
Select a neighboring publication to make it the new centre.